These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37358174)

  • 1. Long-lasting brain fog is related with severity clusters of symptoms in COVID-19 patients.
    Lanz-Luces JR; Aceituno H; Quiroz-Bravo F; Rodríguez-Flores F; Osores-Espinoza M; Rigaud D; Pérez-Cuesta D; Khan A; Tobar-Bustamente A; Barrancas A; Figueroa-Torres C; de la Cruz JG; Burgos-Alarcón F; Gómez-Donoso J
    Rev Med Chil; 2022 Nov; 150(11):1484-1492. PubMed ID: 37358174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Fog and Quality of Life at Work in Non-Hospitalized Patients after COVID-19.
    Chatys-Bogacka Z; Mazurkiewicz I; Slowik J; Bociaga-Jasik M; Dzieza-Grudnik A; Slowik A; Wnuk M; Drabik L
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232113
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-Lasting COVID-Associated Brain Fog: A Follow-Up Study.
    Asadi-Pooya AA; Shahisavandi M; Nemati H; Karimi A; Jafari A; Nasiri S; Mohammadi SS; Nemati M; Rahimian Z; Bayat H
    Eur Neurol; 2023; 86(3):166-170. PubMed ID: 36843124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Exploration of Cortical Brain Activity in Cognitive Fog: An EEG Study in Patients with and without Anosmia.
    Gangemi A; Suriano R; Fabio RA
    J Integr Neurosci; 2024 May; 23(5):105. PubMed ID: 38812399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-related patient-reported brain fog symptoms in non-hospitalised COVID-19 patients.
    Chatys-Bogacka Ż; Mazurkiewicz I; Słowik J; Nowak K; Sydor W; Wizner B; Słowik A; Wnuk M; Drabik L
    Neurol Neurochir Pol; 2023; 57(1):111-120. PubMed ID: 36799525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Clinical Characterisation of Brain Fog in Adults Reporting Long COVID Symptoms.
    Jennings G; Monaghan A; Xue F; Duggan E; Romero-Ortuño R
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trajectory of post-COVID brain fog, memory loss, and concentration loss in previously hospitalized COVID-19 survivors: the LONG-COVID-EXP multicenter study.
    Fernández-de-Las-Peñas C; Cancela-Cilleruelo I; Rodríguez-Jiménez J; Arias-Navalón JA; Martín-Guerrero JD; Pellicer-Valero OJ; Arendt-Nielsen L; Cigarán-Méndez M
    Front Hum Neurosci; 2023; 17():1259660. PubMed ID: 38021227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long COVID syndrome-associated brain fog.
    Asadi-Pooya AA; Akbari A; Emami A; Lotfi M; Rostamihosseinkhani M; Nemati H; Barzegar Z; Kabiri M; Zeraatpisheh Z; Farjoud-Kouhanjani M; Jafari A; Sasannia S; Ashrafi S; Nazeri M; Nasiri S; Shahisavandi M
    J Med Virol; 2022 Mar; 94(3):979-984. PubMed ID: 34672377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Fog: a Narrative Review of the Most Common Mysterious Cognitive Disorder in COVID-19.
    Aghajani Mir M
    Mol Neurobiol; 2023 Oct; ():. PubMed ID: 37874482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patients.
    Chan Sui Ko A; Candellier A; Mercier M; Joseph C; Schmit JL; Lanoix JP; Andrejak C
    Int J Infect Dis; 2022 May; 118():220-223. PubMed ID: 35257903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological and Psychiatric Manifestations of Post-COVID-19 Conditions.
    Jung YH; Ha EH; Park J; Choe KW; Lee WJ; Jo DH
    J Korean Med Sci; 2023 Mar; 38(11):e83. PubMed ID: 36942392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 disease severity and associated factors among Ethiopian patients: A study of the millennium COVID-19 care center.
    Leulseged TW; Abebe KG; Hassen IS; Maru EH; Zewde WC; Chamiso NW; Yegele KT; Bayisa AB; Siyoum DF; Edo MG; Mesfin EG; Derejie MN; Shiferaw HK
    PLoS One; 2022; 17(1):e0262896. PubMed ID: 35085338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective brain fog: a four-dimensional characterization in 25,796 participants.
    Alim-Marvasti A; Ciocca M; Kuleindiren N; Lin A; Selim H; Mahmud M
    Front Hum Neurosci; 2024; 18():1409250. PubMed ID: 38911226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Brain fog', guilt, and gratitude: experiences of symptoms and life changes in older survivors 6 months after hospitalisation for COVID-19.
    Heiberg KE; Heggestad AKT; Jøranson N; Lausund H; Breievne G; Myrstad M; Ranhoff AH; Walle-Hansen MM; Bruun-Olsen V
    Eur Geriatr Med; 2022 Jun; 13(3):695-703. PubMed ID: 35267190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study.
    Chudzik M; Babicki M; Kapusta J; Kałuzińska-Kołat Ż; Kołat D; Jankowski P; Mastalerz-Migas A
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of "brain fog" 1 year after COVID-19 disease.
    Cristillo V; Pilotto A; Piccinelli SC; Gipponi S; Leonardi M; Bezzi M; Padovani A
    Neurol Sci; 2022 Oct; 43(10):5795-5797. PubMed ID: 35930181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.